Trial intelligence / Profile preview

Long-term Follow-up of Darvadstrocel for Complex Perianal Fistula in Crohn's Disease

NCT04075825Phase 3Completed

Sponsor
Takeda
Start
Nov 2019
Primary completion
Apr 2024
Modality
Stem Cell Therapies
Countries
9
01

Overview

A Phase 3 trial of darvadstrocel in perianal fistula, sponsored by Takeda. Started Nov 2019; status: completed.

02

Drugs

darvadstrocel
03

Conditions

perianal fistula

Beyond the preview

Go deeper on NCT04075825.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04075825.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call